REGENERON PHARMACEUTICALS, INC.
REGENERON PHARMACEUTICALS, INC. reported a Form 13F information table total of $47.88 million in 2 entries in its Form 13F-HR for the quarter ended 2026-03-31.
Its holdings by class are not on this site yet.
Form 13F-HR as filed (SEC CIK 872589): holdings report, quarter ended 2026-03-31, filed 2026-05-08; filing manager in United States.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Portland Financial Advisors Inc | United States | $0.048B | 77 |
| Vickerman Investment Advisors, Inc. | United States | $0.048B | 94 |
| Inflection Point Holdings II LLC | United States | $0.047B | 1 |
| FLP Wealth Management, LLC | United States | $0.049B | 53 |
| Capital CS Group, LLC | United States | $0.049B | 61 |
| Global IMC LLC | United States | $0.047B | 16 |
| ClearAlpha Technologies LP | United States | $0.049B | 74 |
| PICKERING ENERGY PARTNERS LP | United States | $0.047B | 19 |
| Firsthand Capital Management, Inc. | United States | $0.047B | 47 |
| New Paradigm Capital Management, LLC | United States | $0.047B | 15 |